National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
denosumab (den-oh-SOO-mab)

 A type of monoclonal antibody being studied in the treatment of multiple myeloma (a cancer that forms in bones) and in the prevention and treatment of bone metastases (cancer that has spread to bone from another organ). Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. Denosumab binds to the protein RANKL and helps keep bone from breaking down. Also called AMG 162.

Previous Definitions:dendritic cell, dendritic cell vaccine, denial, denileukin diftitox, denomination
Next Definitions:dental implant, dentist, Denys-Drash syndrome, deoxycytidine, deoxyribonucleic acid